Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Formulation of Caffeine Nasal Sprays and Its Enhanced Permeation through Rabbit Nasal Mucosa

카페인의 비강 분무액의 제제설계 및 점막 투과 증진

  • Noh, Eun-Sun (College of Pharmacy, Dongduk Women's University) ;
  • Chun, In-Koo (College of Pharmacy, Dongduk Women's University)
  • 노은선 (동덕여자대학교 약학대학) ;
  • 전인구 (동덕여자대학교 약학대학)
  • Published : 2004.04.20
Download PDF
⟨ Previous Next ⟩

Abstract

This study was aimed to investigate the feasibility of nasal delivery of caffeine for the elimination of sleepiness. The effects of various vehicles, solubilizers, and enhancers on the permeation of caffeine through rabbit nasal mucosa was observed. The permeation study was carried out using a Franz-type permeation system at $37^{\circ}C$, and the amount of caffeine permeated though the rabbit nasal mucosa was determined by a validated HPLC. The apparent solubility and phys iochemical stability of caffeine in various nasal formulations were was determined. The effect of hydrotropes and modified cyclodextrins on the solubility of caffeine in water was determined by equilibrium solubility method. The solubility of caffeine in water was 29 mg/mL at $30^{\circ}C$. The addition of sodium benzoate and nicotinamide at 10% improved the solubility of caffeine (115 and 132 mg/mL, respectively) in aqueous solution. The flux of caffeine though the nasal mucosa from aqueous solution was $2.1{\pm}0.26\;mg/cm^2/hr$. The addition of sodium benzoate reduced its permeation $(1.4{\pm}0.01\;mg/cm^2/hr)$, but sodium benzoate with 5% $2HP{\beta}CD$ and 0.03% monoterpenes increased its permeation $(2.4{\pm}0.04\;mg/cm^2/hr)$ markedly. The addition of nicotinamide also increased also increased its permeation $(2.5{\pm}0.36\;mg/cm^2/hr)$. markedly. As the concentration of caffeine in nasal formulation increased, the permeation flux increased linearly. Caffeine was stable physicochemically and enzymatically in the nasal mucosa extract at $37^{\circ}C$. These results suggest that caffeine can be efficiently delivered nasally and the development of nasal formulation will be feasible.

Keywords

References

  1. J.F. Chen, K. Xu, J.P. Petzer, R. Staal, Y.H. Xu, M. Beistein, P.K. Sonsalla, K. Castagnoli, N. Castagnoli and M.A. Schwarzschild, Neuroproteetion by caffeine and A$_{2A}$ adenosine receptors inactivation in an model of Parkinson's disease, J. Neurosci., 21, 1-6 RC143 (2001)
  2. S.E. O'Connell and F.J. Zurzola, Rapid quantitative liquid chromatographic determination of caffeine levels in plasma after oral dosing, J. Pharm. Sci., 73, 1009-1011 (1984) https://doi.org/10.1002/jps.2600730742
  3. J.E.F Reynolds, K. Parfitt, A.V. Parsons and S.C. Sweetman, Ed., Martindale, The Extra Pharmacopoeia, 29th Edition, The Pharmaceutical Press, 1989, pp. 1522-1524
  4. G. Potard, C. Laugel, A. Baillet, H. Schaefer and J.P. Marty, Quantitative HPLC analysis of sunscreens and caffeine during in vitro percutaneous penetration studies, Int. J. Pharm, 189, 249-260 (1999)
  5. F.P. Bonina, V. Carelli, G. Di Colo, L. Montenegro and E. Nannipieri, Vehicle effects on in vitro skin permeation of and stratum corneum affinity for model drugs caffeine and testosterone, Int. J. Pharm., 100, 41-47 (1993)
  6. Huang, C., Kimura, R., Nasser, R. and Hussain, A.A., Mechanism of nasal absorption of drugs I : physicochemical parameters influencing the rate of in-situ nasal absorption of drugs in rats. J. Pharm. Sci., 74, 608-611 (1985) https://doi.org/10.1002/jps.2600740605
  7. K.S.E. Su, K.M. Campanale and C.L. Gries, Nasal drug delivery system of a quaternary ammonium compound: clofilium tosylate, J. Pharm. Sci., 73, 1251-1254 (1984) https://doi.org/10.1002/jps.2600730915
  8. A. Fisher, K. Brown, S. Davis, G. Parr and D.A. Smith, The effect of molecular size on the nasal absorption of watersoluble compounds in the albino rat, J. Pharm. Pharmacol., 39, 367-362 (1987)
  9. T. Sakane, M. Akizuki and M. Yoshida, Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity, J. Pharm. Pharmacol., 43, 449-451 (1990)
  10. T. Sakane, M. Akizuki, S. Yamashida, T. Nadia, M. Hashida and H. Sezaki, The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipiphilicity of the drug, Chem. Pharm. Bull., 39, 2456-2458 (1991) https://doi.org/10.1248/cpb.39.2456
  11. L. Illum, Nasal drug delivery: possibilities, problems and solutions, J. Control. ReI., 87, 187-198 (2003) https://doi.org/10.1016/S0168-3659(02)00363-2
  12. A.A. Hussain, A. Dakkuri and S. Itoh, Nasal absorption of ondansetron in rats : an alternative route of drug delivery, Cancer Chemother. Pharmacol., 45, 432-434 (2000) https://doi.org/10.1007/s002800051014
  13. C.R. Behl, H.K. Pirnplaskar, A.P. Sileno, J. deMeireles and V.D. Romeo, Effects of physicochemical properties and other factors on systemic nasal delivery. Adv. Drug Del. Rev., 29, 89-116 (1998) https://doi.org/10.1016/S0169-409X(97)00063-X
  14. C. Sacchetti, M. Artusi, P. Santi and P. Colombo, Caffeine microparticles for nasal administration obtained by spray drying, Int. J. Pharm., 242, 335-339 (2002)
  15. H.J. Choi and I.K. Chun, Complexation of progesterone with cyclodextrins and design of aqueous parenteral formulations. J. Kor. Pharm. Sci., 31, 151-160 (2001)
  16. H.J. Kim and I.K. Chun, Design and evaluation of biphenyldimethyl dicarboxylate injections, Yakhak Hoeji, 44, 263-271 (2000)
  17. J.H. Moon and I.K. Chun, Enhanced dissolution and permeation of biphenyl dimethyl dicarboxylate using solid dispersions, J. Kor. Pharm. Sci., 29, 227-234 (1999)
  18. A.S. Harris, E. Svensson, Z.G. Wagner, S. Lethagen and I.M. Nilsson, Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin, J. Pharm. Sci., 77, 405-408 (1988) https://doi.org/10.1002/jps.2600770510
  19. T.J. Aspden, J.D.T. Mason, N.S. Jones, J. Lowe, O. Skaugrud and L. Illlum, Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers, J. Pharm. Sci., 86, 509-513 (1997) https://doi.org/10.1021/js960182o
  20. C.R. Behl, H.K. Pirnplaskar, A.P. Sileno, W.J. Xia, W.J. Gries and J.C. deMeireles, Optimization of systemic nasal delivery with pharmaceutical excipients, Adv. Drug Del. Rev., 29, 117-133 (1998) https://doi.org/10.1016/S0169-409X(97)00064-1
  21. K. Matsubara, K. Abe, T. Irie and K. Uekama, Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats, J. Pharm. Sci., 84, 1295-1300 (1995) https://doi.org/10.1002/jps.2600841108
  22. B.W. Barry and A.C. Williams, Terpenes as Skin Penetration Erihancers : In K.A. Waters and J. Hadgraft, Ed., Pharmaceutical Skin Penetration Enhancement, Marcel Dekker, Inc., 1993, pp. 95-111